Reference:
  1. Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012[J]. A summary for otorhinolaryngologists. Rhinology, 2012, 50(1): 1-12.
  2. Shi JB, Fu QL, Zhang H, et al. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities[J]. Allergy, 2015, 70(5): 533-539.
  3. Dykewicz MS, Hamilos DL. Rhinitis and sinusitis[J]. J Allergy Clin Immunol, 2010, 125(2 Suppl 2): S103-S115.
  4. Smith KA, Pulsipher A, Gabrielsen DA, et al. Biologics in Chronic Rhinosinusitis: An Update and Thoughts for Future Directions[J]. Am J Rhinol Allergy, 2018, 32(5): 412-423.
  5. Wang Lihui, Xu Yue,Rogers Heather, Saidi Layla, et al. UFMylation of RPL26 links translocation-associated quality control to endoplasmic reticulum protein homeostasis.[J]. Cell research, 2020, 30(1)
  6. Walczak C, Leto D, Zhang L, et al. Ribosomal protein RPL26 is the principal target of UFMylation.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2019, 116(4).
  7. Deniz S, Gerald C, Ryan A, et al. The Mammalian Ribo-interactome Reveals Ribosome Functional Diversity and Heterogeneity[J]. Cell, 2017, 169(6).
  8. Garreau D, Prokhorova I, Rodnina M, et al. Structural basis for the inhibition of the eukaryotic ribosome.[J]. Nature, 2014, 513(7519).
  9. Person EK,Verstraete K,Heyndrickx I,et al. Protein crystalization promotes type 2immunity and is re- versible by antibody treatment[J]. Science, 2019, 364 (6442):751-765.
  10. Nakayama T, Asaka D, Yoshikawa M, et al. Identification of chronic rhinosinusitis phenotypes using cluster analysis[J]. Am J Rhinol Allergy, 2012, 26(3): 172-176.
  11. Soler ZM, Hyer JM, Ramakrishnan V,et al. Identification of chronic rhinosinusitis phenotypes using cluster analysis[J]. Int Forum Allergy Rhinol, 2015, 5(5): 399-407.
  12. Lou H, Meng Y, Piao Y, et al. Cellular phenotyping of chronic rhinosinusitis with nasal polyps[J]. Rhinology, 2016, 54(2): 150-159.
  13. Wang X, Zhang N, Bo M, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania[J]. J Allergy Clin Immunol, 2016, 138(5): 1344-1353.
  14. Joazeiro CAP. Ribosomal Stalling During Translation: Providing Substrates for Ribosome-Associated Protein Quality Control. Annu Rev Cell Dev Biol. 2017;33:343-368. doi:10.1146/annurev-cellbio-111315-125249.
  15. Brandman O, Hegde RS. Ribosome-associated protein quality control. Nat Struct Mol Biol. 2016;23(1):7-15. doi:10.1038/nsmb.3147.
  16. Simsek D, Tiu GC, Flynn RA, et al. The Mammalian Ribo-interactome Reveals Ribosome Functional Diversity and Heterogeneity. Cell. 2017; 169(6): 1051-1065. e18. doi: 10. 1016/j. cell. 2017.05.022.
  17. Brandman O, Hegde RS. Ribosome-associated protein quality control. Nat Struct Mol Biol. 2016;23(1):7-15. doi:10.1038/nsmb.3147.
  18. Juszkiewicz S, Hegde RS. Initiation of Quality Control during Poly(A) Translation Requires Site-Specific Ribosome Ubiquitination. Mol Cell. 2017; 65(4): 743-750. e4. doi: 10.1016/j.molcel.2016.11.039.
  19. Shao S, Hegde RS. Reconstitution of a minimal ribosome-associated ubiquitination pathway with purified factors. Mol Cell. 2014;55(6):880-890. doi:10.1016/j.molcel.2014.07.006.